Condition
Stem Cell Transplant Complications clinical trials and research
As of November 12, 2026, Find a Trial lists 15 Stem Cell Transplant Complications clinical trials that are recruiting, at sites in 12 countries (most in United States (7), China (5), Canada (3)). By phase: Phase 2 (5), Phase 3 (2), Early Phase 1 (1), Phase 1 (1). The most active sponsors are Chinese PLA General Hospital (3), Dana-Farber Cancer Institute (3), Massachusetts General Hospital (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 12Countries
Newest Stem Cell Transplant Complications clinical trials
All recruiting trials (15)
-
Combining ruxolitinib with corticosteroids for severe acute graft‑versus‑host disease
This trial tests whether adding ruxolitinib to corticosteroids as first‑line treatment helps people who develop severe acute graft‑versus‑host disease after a first stem cell transplant.
-
Venetoclax added to reduced-intensity conditioning for combined stem cell and kidney transplant
This trial tests whether adding venetoclax to a reduced-intensity conditioning regimen is safe for adults with blood cancers who are receiving a combined stem cell and kidney transplant from a matched or partially matched donor.
-
First-line ruxolitinib plus corticosteroids for grade II acute graft-versus-host disease
This trial will test whether adding ruxolitinib to standard corticosteroids helps people with new grade II acute graft-versus-host disease after an allogeneic stem cell transplant.
-
Individualized ATG dosing for stem cell transplantation
This study is testing a personalized approach to dosing a medication for adults receiving stem cell transplants to see if it can reduce complications like infections and improve recovery.
-
Digital application to improve sexual health for stem cell transplant survivors
This study is testing a new app to help survivors of stem cell transplants improve their sexual health and overall well-being.
-
Modified second transplantation for patients with graft failure
This study is testing a new approach to a second stem cell transplant for patients who didn't fully recover after their first transplant to see if it helps them get better, especially with their platelet counts.
-
Second haploidentical stem cell transplantation for graft failure
This study is testing if a second stem cell transplant from a partially matched donor can help patients with blood cancers who had problems with their first transplant.
-
Improving sleep for children undergoing stem cell transplants
This study is testing a program to help children getting stem cell transplants sleep better in the hospital by giving families tools to create a more restful environment.
-
Exercise program for multiple myeloma patients before stem cell transplant
This study tests if a home-based exercise program can help people with multiple myeloma get stronger and healthier before they have a stem cell transplant.
-
Using loratadine to prevent bone pain from G-CSF during stem cell transplants
This study is testing if loratadine can help prevent bone pain in adults with lymphoma or multiple myeloma who are getting stem cell transplants.
-
T-cell therapy for viral infections after stem cell transplant
This study is testing whether giving special T-cells that target specific viruses can help patients who have had a stem cell transplant and are struggling with tough viral infections.
-
New approach to stem cell transplant for high-risk leukemia patients
This study is testing a new type of stem cell transplant for high-risk leukemia patients to see if it can help them recover better and avoid complications.
-
Investigating gut bacteria changes during stem cell transplant
This study is trying to see how antibiotics used during stem cell transplants affect gut bacteria and whether these changes influence complications like graft-versus-host disease and relapse rates in patients.
-
Treatment for Epstein-Barr Virus-Associated Lymphoproliferative Disease After Transplant
This study is testing a new treatment called tabelecleucel for patients with a specific type of cancer related to Epstein-Barr virus who haven't improved with other therapies after receiving a transplant.
-
Nonmyeloablative stem cell transplant for children with sickle cell disease and incompatible donors
This study is testing a new way to do a stem cell transplant for children with sickle cell disease who have a donor that doesn't perfectly match to see if it can help them get better.
Related topics
Quick answers
How many Stem Cell Transplant Complications clinical trials are recruiting right now?
15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (7 trials), China (5 trials), Canada (3 trials), Belgium (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Phase 3: 2, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.